Tumor size and age predict the risk of malignancy in Hürthle cell neoplasm of the thyroid and can therefore guide the extent of initial thyroid surgery

Thyroid

Volumn 20, Issue 11, 2010, Pages 1229-1234

  Kim, Tae Hyuk ^a   Lim, Jung Ah ^a   Ahn, Hwa Young ^a,b   Lee, Eun Kyung ^a   Min, Hye Sook ^c   Won Kim, Kyung ^d   Choi, Yun Hee ^c   Park, Young Joo ^a,b   Park, Do Joon ^a   Kim, Kwang Hyun ^a   Youn, Yeo Kyu ^a   Cho, Bo Youn ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; AGE DISTRIBUTION; ARTICLE; ASPIRATION BIOPSY; CLINICAL FEATURE; CYTODIAGNOSIS; DECISION MAKING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; PATHOLOGY; PATIENT REFERRAL; PATIENT SELECTION; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SUBTOTAL THYROIDECTOMY; THYROID SURGERY; THYROID TUMOR; THYROTROPIN BLOOD LEVEL; TUMOR VOLUME;

ADULT; DECISION MAKING; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY;

EID: 78249264473     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0443     Document Type: Article

References (29)

1. Montone KT, Baloch ZW, Li Volsi VA 2008 The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med 132:1241-1250.
2. Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordonez NG, Sherman SI 2003 Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer 97:1186-1194.
3. McLeod MK, Thompson NW 1990 Hürthle cell neoplasms of the thyroid. Otolaryngol Clin North Am 23:441-452.
4. Watson RG, Brennan MD, Goellner JR, van Heerden JA, McConahey WM, Taylor WF 1984 Invasive Hürthle cell carcinoma of the thyroid: natural history and management. Mayo Clin Proc 59:851-855.
5. Baloch ZW, Li Volsi VA 1999 Oncocytic lesions of the neuroendocrine system. Semin Diagn Pathol 16:190-199.
6. Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, Shah JP, Fremgen AM, Stewart AK, Holzer S 2000 Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U. S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 89:202-217.
7. Giorgadze T, Rossi ED, Fadda G, Gupta PK, Livolsi VA, Baloch Z 2004 Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy? Diagn Cytopathol 31:307-312.
8. Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW 2006 Does Hürthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn Cytopathol 34:330-334.
9. Sippel RS, Elaraj DM, Khanafshar E, Zarnegar R, Kebebew E, Duh QY, Clark OH 2008 Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid. World J Surg 32:702-707.
10. Wu HH, Clouse J, Ren R 2008 Fine-needle aspiration cytology of Hürthle cell carcinoma of the thyroid. Diagn Cytopathol 36:149-154.
11. Renshaw AA 2002 Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria. Cancer 96:261-266.
12. Alaedeen DI, Khiyami A, McHenry CR 2005 Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease. Surgery 138:650-656; discussion 656-657.
13. Ongphiphadhanakul B, Rajatanavin R, Chiemchanya S, Chailurkit L, Kongsuksai A, Isarangkul Na Ayuthya WI 1992 Systematic inclusion of clinical and laboratory data improves diagnostic accuracy of fine-needle aspiration biopsy in solitary thyroid nodules. Acta Endocrinol (Copenh) 126:233-237.
14. Elliott DD, Pitman MB, Bloom L, Faquin WC 2006 Fineneedle aspiration biopsy of Hürthle cell lesions of the thyroid gland: a cytomorphologic study of 139 cases with statistical analysis. Cancer 108:102-109.
15. Li Volsi VA 1990 Surgical Pathology of the Thyroid. WB Saunders, Philadelphia.
16. Obuchowski NA 2003 Receiver operating characteristic curves and their use in radiology. Radiology 229:3-8.
17. Grube E, Bootsveld A, Yuecel S, Shen JT, Imhoff M 2007 Computerized two-lead resting ECG analysis for the detection of coronary artery stenosis. Int J Med Sci 4:249-263.
18. Schisterman EF, Perkins NJ, Liu A, Bondell H 2005 Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 16:73-81.
19. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S 1997 A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 16:965-980.
20. Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, Kim J, Kim HS, Byun JS, Lee DH 2008 Benign and malignant thyroid nodules: US differentiation- multicenter retrospective study. Radiology 247:762-770.
21. Hedinger CWE, Sobin LH 1988 WHO. Histologic Typing of Thyroid Tumors. Springer-Verlag, New York.
22. Pisanu A, Sias L, Uccheddu A 2004 Factors predicting malignancy of Hürthle cell tumors of the thyroid: influence on surgical treatment. World J Surg 28:761-765.
23. Chen H, Nicol TL, Zeiger MA, Dooley WC, Ladenson PW, Cooper DS, Ringel M, Parkerson S, Allo M, Udelsman R 1998 Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann Surg 227:542-546.
24. Apel RL, Asa SL, Li Volsi VA 1995 Papillary Hürthle cell carcinoma with lymphocytic stroma. "Warthin-like tumor" of the thyroid. Am J Surg Pathol 19:810-814.
25. McHenry CR, Thomas SR, Slusarczyk SJ, Khiyami A 1999 Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? Surgery 126:798-802; discussion 802-804.
26. Arganini M, Behar R, Wu TC, Straus F 2nd, McCormick M, De Groot LJ, Kaplan EL 1986 Hürthle cell tumors: a twentyfive-year experience. Surgery 100:1108-1115.
27. Tuttle RM, Lemar H, Burch HB 1998 Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 8:377-383.
28. Yang GC, Goldberg JD, Ye PX 2003 Risk of malignancy in follicular neoplasms without nuclear atypia: statistical analysis of 397 thyroidectomies. Endocr Pract 9:510-516.
29. Faraggi D, Simon R 1996 A simulation study of crossvalidation for selecting an optimal cutpoint in univariate survival analysis. Stat Med 15:2203-2213.